Copyright © 2008 The American Society of Human Genetics. All rights reserved.
The American Journal of Human Genetics, Volume 82, Issue 1, 19-31, 10 January 2008
doi:10.1016/j.ajhg.2007.08.004
Article
Rosemary Burgess1, 8, Ian D. Millar2, Bart P. Leroy3, 4, Jill E. Urquhart1, 8, Ian M. Fearon2, Elfrida De Baere4, Peter D. Brown2, Anthony G. Robson5, 6, Genevieve A. Wright5, Philippe Kestelyn3, Graham E. Holder5, 6, Andrew R. Webster5, 6, Forbes D.C. Manson1, 7, 8 and Graeme C.M. Black1, 7, 8,
, 
1 Academic Unit of Medical Genetics and Regional Genetics Service, St. Mary's Hospital, Hathersage Road, Manchester M13 0JH, UK
2 Faculty of Life Sciences, Core Technology Facility, University of Manchester, Manchester M13 9NT, UK
3 Department of Ophthalmology, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium
4 Centre for Medical Genetics, Ghent University Hospital, De Pintelaan 185, 9000 Ghent, Belgium
5 Moorfields Eye Hospital, 162 City Road, London EC1V 2PD, UK
6 UCL Institute of Ophthalmology, University College of London, 11-43 Bath Street, London EC1V 9EL, UK
7 Academic Department of Ophthalmology, Manchester Royal Eye Hospital, Oxford Road, Manchester, M13 9WH, UK
8 Centre for Molecular Medicine, Stopford Building, University of Manchester, Oxford Road, Manchester, M13 9PT, UK
Corresponding authorAbstract
We describe a distinct retinal disorder, autosomal-recessive bestrophinopathy (ARB), that is consequent upon biallelic mutation in BEST1 and is associated with central visual loss, a characteristic retinopathy, an absent electro-oculogram light rise, and a reduced electroretinogram. Heterozygous mutations in BEST1 have previously been found to cause the two dominantly inherited disorders, Best macular dystrophy and autosomal-dominant vitreoretinochoroidopathy. The transmembrane protein bestrophin-1, encoded by BEST1, is located at the basolateral membrane of the retinal pigment epithelium in which it probably functions as a Cl− channel. We sequenced BEST1 in five families, identifying DNA variants in each of ten alleles. These encoded six different missense variants and one nonsense variant. The alleles segregated appropriately for a recessive disorder in each family. No clinical or electrophysiological abnormalities were identified in any heterozygotes. We conducted whole-cell patch-clamping of HEK293 cells transfected with bestrophin-1 to measure the Cl− current. Two ARB missense isoforms severely reduced channel activity. However, unlike two other alleles previously associated with Best disease, cotransfection with wild-type bestrophin-1 did not impair the formation of active wild-type bestrophin-1 channels, consistent with the recessive nature of the condition. We propose that ARB is the null phenotype of bestrophin-1 in humans.
| CNGA3 Mutations in Hereditary Cone Photoreceptor Disorders The American Journal of Human Genetics, Volume 69, Issue 4, 1 October 2001, Pages 722-737 Bernd Wissinger, Daphne Gamer, Herbert Jägle, Roberto Giorda, Tim Marx, Simone Mayer, Sabine Tippmann, Martina Broghammer, Bernhard Jurklies, Thomas Rosenberg, Samuel G. Jacobson, E. Cumhur Sener, Sinan Tatlipinar, Carel B. Hoyng, Claudio Castellan, Pierre Bitoun, Sten Andreasson, Günter Rudolph, Ulrich Kellner, Birgit Lorenz, Gerhard Wolff, Christine Verellen-Dumoulin, Marianne Schwartz, Frans P.M. Cremers, Eckart Apfelstedt-Sylla, Eberhart Zrenner, Roberto Salati, Lindsay T. Sharpe and Susanne Kohl Abstract We recently showed that mutations in the CNGA3 gene encoding the α-subunit of the cone photoreceptor cGMP-gated channel cause autosomal recessive complete achromatopsia linked to chromosome 2q11. We now report the results of a first comprehensive screening for CNGA3 mutations in a cohort of 258 additional independent families with hereditary cone photoreceptor disorders. CNGA3 mutations were detected not only in patients with the complete form of achromatopsia but also in incomplete achromats with residual cone photoreceptor function and (rarely) in patients with evidence for severe progressive cone dystrophy. In total, mutations were identified in 53 independent families comprising 38 new CNGA3 mutations, in addition to the 8 mutations reported elsewhere. Apparently, both mutant alleles were identified in 47 families, including 16 families with presumed homozygous mutations and 31 families with two heterozygous mutations. Single heterozygous mutations were identified in six additional families. The majority of all known CNGA3 mutations (39/46) are amino acid substitutions compared with only four stop-codon mutations, two 1-bp insertions and one 3-bp in-frame deletion. The missense mutations mostly affect amino acids conserved among the members of the cyclic nucleotide gated (CNG) channel family and cluster at the cytoplasmic face of transmembrane domains (TM) S1 and S2, in TM S4, and in the cGMP-binding domain. Several mutations were identified recurrently (e.g., R277C, R283W, R436W, and F547L). These four mutations account for 41.8% of all detected mutant CNGA3 alleles. Haplotype analysis suggests that the R436W and F547L mutant alleles have multiple origins, whereas we found evidence that the R283W alleles, which are particularly frequent among patients from Scandinavia and northern Italy, have a common origin. Abstract | | |
| Mutations in the Gene KCNV2 Encoding a Voltage-Gated Potassium Channel Subunit Cause “Cone Dystrophy with Supernormal Rod Electroretinogram” in Humans The American Journal of Human Genetics, Volume 79, Issue 3, 1 September 2006, Pages 574-579 Huimin Wu, Jill A. Cowing, Michel Michaelides, Susan E. Wilkie, Glen Jeffery, Sharon A. Jenkins, Viktoria Mester, Alan C. Bird, Anthony G. Robson, Graham E. Holder, Anthony T. Moore, David M. Hunt and Andrew R. Webster Abstract “Cone dystrophy with supernormal rod electroretinogram (ERG)” is an autosomal recessive disorder that causes lifelong visual loss combined with a supernormal ERG response to a bright flash of light. We have linked the disorder to a 0.98-cM (1.5-Mb) region on chromosome 9p24, flanked by rs1112534 and rs1074449, using homozygosity mapping in one large consanguineous pedigree. Analysis of one gene within this region, KCNV2, showed a homozygous nonsense mutation. Mutations were also found in 17 alleles of 10 other unrelated families with the same disorder. In situ hybridization demonstrated KCNV2 expression in human rod and cone photoreceptors. The precise function of KCNV2 in human photoreceptors remains to be determined, although this work suggests that mutations might perturb or abrogate IKX, the potassium current within vertebrate photoreceptor inner segments, which has been shown to set their resting potential and voltage response. Abstract | | |
| Mutation in the Auxiliary Calcium-Channel Subunit CACNA2D4 Causes Autosomal Recessive Cone Dystrophy The American Journal of Human Genetics, Volume 79, Issue 5, 1 November 2006, Pages 973-977 Katharina Agnes Wycisk, Christina Zeitz, Silke Feil, Mariana Wittmer, Ursula Forster, John Neidhardt, Bernd Wissinger, Eberhart Zrenner, Robert Wilke, Susanne Kohl and Wolfgang Berger Abstract Retinal signal transmission depends on the activity of high voltage–gated l-type calcium channels in photoreceptor ribbon synapses. We recently identified a truncating frameshift mutation in the Cacna2d4 gene in a spontaneous mouse mutant with profound loss of retinal signaling and an abnormal morphology of ribbon synapses in rods and cones. The Cacna2d4 gene encodes an l-type calcium-channel auxiliary subunit of the α2δ type. Mutations in its human orthologue, CACNA2D4, were not yet known to be associated with a disease. We performed mutation analyses of 34 patients who received an initial diagnosis of night blindness, and, in two affected siblings, we detected a homozygous nucleotide substitution (c.2406C→A) in CACNA2D4. The mutation introduces a premature stop codon that truncates one-third of the corresponding open reading frame. Both patients share symptoms of slowly progressing cone dystrophy. These findings represent the first report of a mutation in the human CACNA2D4 gene and define a novel gene defect that causes autosomal recessive cone dystrophy. Abstract | | |